Scientists are developing anticancer compounds targeting a pathway of the endoplasmic reticulum (ER) stress response implicated in the development of multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and lymphoma.
Click here for original story, Anticancer compounds for B cell cancer therapy targeting cellular stress response
Source: ScienceDaily